Research Project
Project Title: |
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IGAN) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
To evaluate the effect of OMS721 in patients with IgA nephropathy (IgAN) onproteinuria assessed by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from baseline. |
Lead principal investigator(s): |
Loreto Gesualdo, Bari |
Co-investigator(s): |
F Annese, Bari F Papadia, Bari |
Project Period: |
05/2022 - 04/2023 |
Sponsors: |
Industry |
ClinicalTrials.gov: |
NCT03608033 |
« Back to research page